Dr. Cyrus Arash Kholdani, MD

Dr. Kholdani practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Dr. Kholdani's NPI, 1235373796, was assigned on April 28, 2009. Dr. Kholdani holds Massachusetts license 274661.

Dr. Kholdani's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Dr. Kholdani's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Dr. Kholdani is also affiliated with Lahey Clinic. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP). Dmand AI also links Dr. Kholdani to 3 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kholdani practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Kholdani's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Kholdani's licenses on file in 2 states: Massachusetts and California.

CMS data shows 1,039 Medicare services from Dr. Kholdani across 18 procedure codes in 2024, for 531 Medicare patients. Medicare paid $57,979 for them.

CMS counts 531 Medicare patients who saw Dr. Kholdani in 2024. The largest group is 75 to 84, with 213 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kholdani's median patient age at 73, with 60% women.

In 2024, Dr. Kholdani wrote 540 Medicare Part D claims for 58 patients. 58% of them were for generic drugs. CMS names the drug for 448 of them, across 12 drugs with 11 or more claims each, at $2,935,049 in total drug cost. In 2023, CMS named 458 claims across 12 drugs.

Dr. Kholdani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kholdani as offering telehealth.

Dmand AI links 11 papers to Dr. Kholdani, published from 2015 to 2025. 2015 was the busiest year, with 2. The most frequent topics are Hypertension, Pulmonary, Heart Failure and Heart Ventricles. Dr. Kholdani has published most often in Clin Chest Med. Dr. Kholdani's most frequent co-authors are Wassim H. Fares, MD, MS, Robert William Hallowell, MD and Roham Tahmaseb Zamanian, MD.

CMS Open Payments shows 75 general payments to Dr. Kholdani from 7 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 78% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $5,847.